세계의 최소침습 수술 기기 시장 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.

MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.

North America Leads the Market in 2024

North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.

Market Size Overview (2024-2032)

• 2024: USD 19.07 billion
• 2025: USD 20.27 billion
• 2032: USD 34.93 billion

The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.

Key Country Highlights

United States

The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.

Japan

An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.

China

With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.

Europe

Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.

Market Dynamics

Drivers - Rising Chronic Conditions

Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.

Restraints - High Cost of MIS Technologies

Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.

Opportunities - Growth of Ambulatory Surgical Centers

With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.

Challenges - Shortage of Skilled Surgeons

The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.

Market Trends

Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.

Competitive Landscape

The market is dominated by industry leaders such as:

• Medtronic
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Stryker
• Olympus Corporation
• Boston Scientific
• Intuitive Surgical

These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.

Recent developments include:

• April 2025: Medtronic expands its URO robotic surgery clinical trial.
• March 2024: Intuitive receives FDA clearance for da Vinci 5.
• 2023-2024: Stryker introduces new minimally invasive surgical probe and 1788 MIS camera platform.

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.

MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.

North America Leads the Market in 2024

North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.

Market Size Overview (2024-2032)

• 2024: USD 19.07 billion
• 2025: USD 20.27 billion
• 2032: USD 34.93 billion

The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.

Key Country Highlights

United States

The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.

Japan

An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.

China

With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.

Europe

Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.

Market Dynamics

Drivers - Rising Chronic Conditions

Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.

Restraints - High Cost of MIS Technologies

Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.

Opportunities - Growth of Ambulatory Surgical Centers

With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.

Challenges - Shortage of Skilled Surgeons

The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.

Market Trends

Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.

Competitive Landscape

The market is dominated by industry leaders such as:

• Medtronic
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Stryker
• Olympus Corporation
• Boston Scientific
• Intuitive Surgical

These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.

Recent developments include:

• April 2025: Medtronic expands its URO robotic surgery clinical trial.
• March 2024: Intuitive receives FDA clearance for da Vinci 5.
• 2023-2024: Stryker introduces new minimally invasive surgical probe and 1788 MIS camera platform.

Segmentation By Type

• Inflation Devices
• Guiding Devices
• Endoscopic Devices
• Laparoscopic Devices
• Robotic Assistive Surgery Devices
• Navigation & Visualization Systems
• Others

By Application

• Cardiology
• Gastrointestinal
• Orthopedic
• Gynecological
• Neurology
• Dental
• Others

By End-user

• Hospitals & ASCs
• Clinics
• Others

By Geography

• North America (By Type, Application, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Type, Application, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Type, Application, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Key Surgeries, By Key Countries/Region, 2024
• 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
• 4.3. Overview: Regulatory & Reimbursement Scenario
• 4.4. New Product Launches, By Key Players

5. Global Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Inflation Devices
  • 5.1.2. Guiding Devices
  • 5.1.3. Endoscopic Devices
  • 5.1.4. Laparoscopic Devices
  • 5.1.5. Robotic Assistive Surgery Devices
  • 5.1.6. Navigation & Visualization Systems
  • 5.1.7. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Cardiology
  • 5.2.2. Gastrointestinal
  • 5.2.3. Orthopedic
  • 5.2.4. Gynecological
  • 5.2.5. Neurology
  • 5.2.6. Dental
  • 5.2.7. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Inflation Devices
  • 6.1.2. Guiding Devices
  • 6.1.3. Endoscopic Devices
  • 6.1.4. Laparoscopic Devices
  • 6.1.5. Robotic Assistive Surgery Devices
  • 6.1.6. Navigation & Visualization Systems
  • 6.1.7. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Cardiology
  • 6.2.2. Gastrointestinal
  • 6.2.3. Orthopedic
  • 6.2.4. Gynecological
  • 6.2.5. Neurology
  • 6.2.6. Dental
  • 6.2.7. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Inflation Devices
  • 7.1.2. Guiding Devices
  • 7.1.3. Endoscopic Devices
  • 7.1.4. Laparoscopic Devices
  • 7.1.5. Robotic Assistive Surgery Devices
  • 7.1.6. Navigation & Visualization Systems
  • 7.1.7. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Cardiology
  • 7.2.2. Gastrointestinal
  • 7.2.3. Orthopedic
  • 7.2.4. Gynecological
  • 7.2.5. Neurology
  • 7.2.6. Dental
  • 7.2.7. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia pacific Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Inflation Devices
  • 8.1.2. Guiding Devices
  • 8.1.3. Endoscopic Devices
  • 8.1.4. Laparoscopic Devices
  • 8.1.5. Robotic Assistive Surgery Devices
  • 8.1.6. Navigation & Visualization Systems
  • 8.1.7. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Cardiology
  • 8.2.2. Gastrointestinal
  • 8.2.3. Orthopedic
  • 8.2.4. Gynecological
  • 8.2.5. Neurology
  • 8.2.6. Dental
  • 8.2.7. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Inflation Devices
  • 9.1.2. Guiding Devices
  • 9.1.3. Endoscopic Devices
  • 9.1.4. Laparoscopic Devices
  • 9.1.5. Robotic Assistive Surgery Devices
  • 9.1.6. Navigation & Visualization Systems
  • 9.1.7. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Cardiology
  • 9.2.2. Gastrointestinal
  • 9.2.3. Orthopedic
  • 9.2.4. Gynecological
  • 9.2.5. Neurology
  • 9.2.6. Dental
  • 9.2.7. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Inflation Devices
  • 10.1.2. Guiding Devices
  • 10.1.3. Endoscopic Devices
  • 10.1.4. Laparoscopic Devices
  • 10.1.5. Robotic Assistive Surgery Devices
  • 10.1.6. Navigation & Visualization Systems
  • 10.1.7. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Cardiology
  • 10.2.2. Gastrointestinal
  • 10.2.3. Orthopedic
  • 10.2.4. Gynecological
  • 10.2.5. Neurology
  • 10.2.6. Dental
  • 10.2.7. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & ASCs
  • 10.3.2. Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Medtronic
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Johnson & Johnson Services, Inc.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Koninklijke Philips N.V.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Boston Scientific Corporation
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Olympus Corporation
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Stryker
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. B. Braun SE
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Steris
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Intuitive Surgical
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)